The Army should discontinue further research and development funding for the Armored Medical Evacuation Vehicle because the service does not have a viable acquisition strategy for it, the Pentagon inspector general says in a new report . The AMEV, a Bradley Fighting Vehicle-based battlefield ambulance, was allowed to enter engineering and manufacturing development without full funding for the program's production phase, the IG states. Accordingly, the Army obligated about $9.7 million in research, development, test and evaluation funding for the...
